Nrx Pharmaceuticals Stock Buy Hold or Sell Recommendation
| NRXP Stock | USD 1.31 0.02 1.55% |
Given the investment horizon of 90 days and your way above-average risk tolerance, our recommendation regarding NRX Pharmaceuticals is 'Hold'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell NRX Pharmaceuticals given historical horizon and risk tolerance towards NRX Pharmaceuticals. When Macroaxis issues a 'buy' or 'sell' recommendation for NRX Pharmaceuticals, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out NRX Pharmaceuticals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. To learn how to invest in NRX Stock, please use our How to Invest in NRX Pharmaceuticals guide. Note, we conduct extensive research on individual companies such as NRX and provide practical buy, sell, or hold advice based on investors' constraints. NRX Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
NRX |
Execute NRX Pharmaceuticals Buy or Sell Advice
The NRX recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on NRX Pharmaceuticals. Macroaxis does not own or have any residual interests in NRX Pharmaceuticals or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute NRX Pharmaceuticals' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Hold
Market Performance | Very Weak | Details | |
Volatility | Very risky | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Actively responds to the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
NRX Pharmaceuticals Trading Alerts and Improvement Suggestions
| NRX Pharmaceuticals generated a negative expected return over the last 90 days | |
| NRX Pharmaceuticals may become a speculative penny stock | |
| NRX Pharmaceuticals has high historical volatility and very poor performance | |
| NRX Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (30.15 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| NRX Pharmaceuticals currently holds about 24.55 M in cash with (21.66 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.36. | |
| NRX Pharmaceuticals has a poor financial position based on the latest SEC disclosures | |
| Roughly 24.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: NRx Pharmaceuticals, Inc. Announces Receipt of Po - GuruFocus.com |
NRX Pharmaceuticals Returns Distribution Density
The distribution of NRX Pharmaceuticals' historical returns is an attempt to chart the uncertainty of NRX Pharmaceuticals' future price movements. The chart of the probability distribution of NRX Pharmaceuticals daily returns describes the distribution of returns around its average expected value. We use NRX Pharmaceuticals price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of NRX Pharmaceuticals returns is essential to provide solid investment advice for NRX Pharmaceuticals.
| Mean Return | -0.53 | Value At Risk | -6.12 | Potential Upside | 6.51 | Standard Deviation | 3.95 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of NRX Pharmaceuticals historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
NRX Stock Institutional Investors
The NRX Pharmaceuticals' institutional investors refer to entities that pool money to purchase NRX Pharmaceuticals' securities or originate loans. These institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds.
| Shares | Bank Of America Corp | 2024-06-30 | 3.3 K | Wells Fargo & Co | 2024-06-30 | 1.5 K | Ubs Group Ag | 2024-06-30 | 1.1 K | Goss Wealth Management Llc | 2024-06-30 | 583 | Qube Research & Technologies | 2024-06-30 | 117 | Harbour Investments, Inc. | 2024-09-30 | 47.0 | Jpmorgan Chase & Co | 2024-06-30 | 34.0 | Larson Financial Group, Llc | 2024-06-30 | 22.0 | Vanguard Group Inc | 2024-09-30 | 240.3 K | Anson Funds Management Lp | 2024-09-30 | 142.5 K | Advisorshares Investments, Llc | 2024-09-30 | 130.1 K |
NRX Pharmaceuticals Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | (11.1K) | 982K | 25.7M | (7.6M) | (15.5M) | (14.7M) | |
| Free Cash Flow | (792.7K) | (2.3M) | (37.7M) | (39.8M) | (21.7M) | (22.7M) | |
| Other Non Cash Items | (1.3M) | 39.6M | 54.3M | (4.3M) | 2.9M | 2.8M | |
| Capital Expenditures | 3.55 | 2K | 7K | 10K | 3K | 3.5K | |
| Net Income | 408.4K | (51.8M) | (93.1M) | (39.8M) | (30.2M) | (31.7M) | |
| End Period Cash Flow | 6.0 | 1.9M | 27.6M | 20.1M | 4.6M | 8.6M |
NRX Pharmaceuticals Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to NRX Pharmaceuticals or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that NRX Pharmaceuticals' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a NRX stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.74 | |
β | Beta against Dow Jones | 1.68 | |
σ | Overall volatility | 3.72 | |
Ir | Information ratio | -0.17 |
NRX Pharmaceuticals Volatility Alert
NRX Pharmaceuticals exhibits very low volatility with skewness of 0.34 and kurtosis of 1.91. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure NRX Pharmaceuticals' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact NRX Pharmaceuticals' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.NRX Pharmaceuticals Fundamentals Vs Peers
Comparing NRX Pharmaceuticals' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze NRX Pharmaceuticals' direct or indirect competition across all of the common fundamentals between NRX Pharmaceuticals and the related equities. This way, we can detect undervalued stocks with similar characteristics as NRX Pharmaceuticals or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of NRX Pharmaceuticals' fundamental indicators could also be used in its relative valuation, which is a method of valuing NRX Pharmaceuticals by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare NRX Pharmaceuticals to competition |
| Fundamentals | NRX Pharmaceuticals | Peer Average |
| Return On Equity | -6.83 | -0.31 |
| Return On Asset | -1.16 | -0.14 |
| Current Valuation | 20.62 M | 16.62 B |
| Shares Outstanding | 12.09 M | 571.82 M |
| Shares Owned By Insiders | 23.56 % | 10.09 % |
| Shares Owned By Institutions | 6.00 % | 39.21 % |
| Number Of Shares Shorted | 667 K | 4.71 M |
| Price To Book | 2.90 X | 9.51 X |
| EBITDA | (30.02 M) | 3.9 B |
| Net Income | (30.15 M) | 570.98 M |
| Cash And Equivalents | 24.55 M | 2.7 B |
| Cash Per Share | 0.36 X | 5.01 X |
| Total Debt | 9.16 M | 5.32 B |
| Debt To Equity | 0.02 % | 48.70 % |
| Current Ratio | 4.58 X | 2.16 X |
| Book Value Per Share | (1.42) X | 1.93 K |
| Cash Flow From Operations | (21.66 M) | 971.22 M |
| Short Ratio | 4.80 X | 4.00 X |
| Earnings Per Share | (2.11) X | 3.12 X |
| Target Price | 31.33 | |
| Beta | 1.27 | -0.15 |
| Market Capitalization | 15.6 M | 19.03 B |
| Total Asset | 7.32 M | 29.47 B |
| Retained Earnings | (253.15 M) | 9.33 B |
| Working Capital | (12.16 M) | 1.48 B |
| Net Asset | 7.32 M |
Note: Disposition of 162500 shares by Van Voorhees Seth of NRX Pharmaceuticals at 0.514 subject to Rule 16b-3 [view details]
NRX Pharmaceuticals Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as NRX . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 2807.72 | |||
| Daily Balance Of Power | 0.4 | |||
| Rate Of Daily Change | 1.02 | |||
| Day Median Price | 1.32 | |||
| Day Typical Price | 1.31 | |||
| Price Action Indicator | 0.005 | |||
| Period Momentum Indicator | 0.02 |
About NRX Pharmaceuticals Buy or Sell Advice
When is the right time to buy or sell NRX Pharmaceuticals? Buying financial instruments such as NRX Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having NRX Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Electronics Thematic Idea Now
Electronics
Companies manufacturing electronic appliances and goods. The Electronics theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Electronics Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for NRX Stock Analysis
When running NRX Pharmaceuticals' price analysis, check to measure NRX Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NRX Pharmaceuticals is operating at the current time. Most of NRX Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of NRX Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NRX Pharmaceuticals' price. Additionally, you may evaluate how the addition of NRX Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.